by Charles Lambalot, Millipore Corporation
Biopharmaceutical Analysis
Latest News
Affinity Chromatography — from Textile Dyes to Synthetic Ligands by Design, Part I
By John Curling
Advertisement
Why Automation with the Correct Liquid Handler is Integral to Improved NGS Outcomes
NGS abbreviates drug discovery timelines.
Biologics Quality Control: The Growing Need for Accessible Proteomics
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
Navigating Challenges in Cell Therapy Potency Assays
Developing cell-based potency assays for cell therapies requires meticulous coordination.
Advertisement
by Suzanne Mattingly, Scimagix, Inc.
by Mary Ellen Goffredo, NuGenesis Technologies Corporation Weighing the Options
by Jane Turton, Central Public Health Laboratory and Zain Moola This case study shows that storing an ion-exchange chromatography gel in dilute alkalai, followed by removal of the solubized material, enhances gel cleaning. More material is removed from the gel during column recycling, and carry over of material from one cycle to the next is substantially reduced.
By Jim Erickson, Blue Mountain Quality Resources, Inc., pp. 63-64. In the fast-paced biopharmaceutical manufacturing environment, "speed to market" is the hallmark catch phrase. Many companies are focusing only on the processes that add the most value and are outsourcing the rest. This focus on core competencies has some biotech companies reevaluating their calibration practices. Many are contracting more of that workload, from both laboratory and production facilities, to calibration service laboratories.
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5